Literature DB >> 7517433

Sialoglycoproteins that bind influenza A virus and resist viral neuraminidase in different animal sera.

T Suzuki1, M Tsukimoto, M Kobayashi, A Yamada, Y Kawaoka, R G Webster, Y Suzuki.   

Abstract

Sialoglycoproteins that are resistant to degradation by viral neuraminidase can effectively neutralize influenza A viruses, because they bind irreversibly to the viruses. To detect such proteins in animal sera, we developed an immunochemical assay based on Western blotting techniques. We assessed the binding activity of sialoglycoproteins in sera from nine different animals toward the A/Aichi/2/68 (H3N2) and A/PR/8/34 (H1N1) strains of influenza virus, with or without viral and bacterial neuraminidase treatment. Using this assay, we found that animal sera contain a spectrum of sialoglycoproteins defined by differing abilities to bind influenza A viruses and to resist the viral neuraminidase. Structural analysis of these inhibitors would provide useful information for the development of anti-influenza virus compounds.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7517433     DOI: 10.1099/0022-1317-75-7-1769

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  3 in total

1.  Fetal calf serum inhibits virus genome expression in Madin-Darby canine kidney cells persistently infected with influenza A virus.

Authors:  Md Jaber Hossain; Isamu Mori; Li Dong; Beixing Liu; Yoshinobu Kimura
Journal:  Med Microbiol Immunol       Date:  2007-07-05       Impact factor: 3.402

2.  Neutrophils play an essential role in cooperation with antibody in both protection against and recovery from pulmonary infection with influenza virus in mice.

Authors:  Haruo Fujisawa
Journal:  J Virol       Date:  2008-01-09       Impact factor: 5.103

Review 3.  Bitter-sweet symphony: glycan-lectin interactions in virus biology.

Authors:  Wander Van Breedam; Stefan Pöhlmann; Herman W Favoreel; Raoul J de Groot; Hans J Nauwynck
Journal:  FEMS Microbiol Rev       Date:  2013-12-06       Impact factor: 16.408

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.